We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery

News   May 05, 2011

 
Cenix BioScience Signs Collaboration and Technology License Agreement for In Vivo siRNA Delivery
 
 
 

RELATED ARTICLES

$27 Million Grant Focuses on the Future of Biomanufacturing

News

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

READ MORE

Transporting an Anti-cancer Agent to Cells Using Nanoparticles

News

Metal-organic frameworks (MOFs) could be used as a platform for delivering a potent anti-cancer agent, called siRNA, to cells.

READ MORE

Gene Therapy Reduces Obesity and Reverses Metabolic Disease in Mice

News

In a study published in Genome Research, researchers developed a gene therapy that specifically reduces fat tissue and reverses obesity-related metabolic disease in obese mice.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE